Cardiology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
Naradhiwas Rajanagarindra Heart Center, Songklanagarind Hospital, Songkhla 90110, Thailand.
Eur Heart J Acute Cardiovasc Care. 2021 Dec 6;10(9):1065-1073. doi: 10.1093/ehjacc/zuab070.
The Mayo Cardiac Intensive Care Unit Admission Risk Score (M-CARS) had excellent performance in predicting in-hospital mortality in the US population. We sought to validate the M-CARS for in-hospital and post-discharge mortality in Asian patients admitted to the cardiac care unit (CCU).
Patients admitted to the CCU of a tertiary care centre between July 2015 and December 2019 were included into the study. Patients with intra-hospital transfer to the CCU due to intensive care unit overflow, postoperative cardiac surgery, or for monitoring after elective procedures were excluded. Cardiac arrest, cardiogenic shock, respiratory failure, Braden skin score, blood urea nitrogen, anion gap, and red cell distribution width, were used to calculate the M-CARS. Patients were stratified into three groups, according to the M-CARS (<2, 2-6, >6). Of 1988 patients in the study, 30.1% were female with a median age of 65 years. Prevalence of cardiogenic shock and respiratory failure at admission were 2.8% and 4.5%, respectively. One hundred and seventeen patients died during the admission (mortality rate of 5.9%). The in-hospital mortality rate in patients with M-CARS of <2, 2-6, and >6 was 1.1%, 9.8%, and 35.5%, respectively. C-statistic of M-CARS for in-hospital mortality was 0.840 (95% CI 0.805-0.873); whereas, it was 0.727 (95% CI 0.690-0.761) for 1-year post-discharge mortality. Calibration plot showed good agreement between predicted and observed in-hospital mortality in the majority of patients.
The M-CARS was useful in our study, in terms of discrimination and calibration. M-CARS identified high-risk patients in CCU, who had unacceptably high mortality rate during hospital stay and thereafter.
梅奥心脏重症监护病房入院风险评分(M-CARS)在美国人群中预测院内死亡率的表现优异。我们试图验证 M-CARS 对亚洲患者入住心脏监护病房(CCU)的院内和出院后死亡率的预测能力。
本研究纳入 2015 年 7 月至 2019 年 12 月期间在三级医疗中心 CCU 住院的患者。排除因 ICU 溢出、心脏手术后转入 CCU、或择期手术后进行监测而在院内转 CCU 的患者。使用心脏骤停、心源性休克、呼吸衰竭、Braden 皮肤评分、血尿素氮、阴离子间隙和红细胞分布宽度来计算 M-CARS。根据 M-CARS(<2、2-6、>6)将患者分为三组。在纳入的 1988 例患者中,30.1%为女性,中位年龄为 65 岁。入院时心源性休克和呼吸衰竭的患病率分别为 2.8%和 4.5%。117 例患者在住院期间死亡(死亡率为 5.9%)。M-CARS<2、2-6 和>6 的患者院内死亡率分别为 1.1%、9.8%和 35.5%。M-CARS 预测院内死亡率的 C 统计量为 0.840(95%CI 0.805-0.873);而 1 年出院后死亡率的 C 统计量为 0.727(95%CI 0.690-0.761)。校准图显示,在大多数患者中,预测与观察到的院内死亡率之间存在良好的一致性。
M-CARS 在本研究中具有良好的区分度和校准度。M-CARS 可识别 CCU 中的高危患者,这些患者在住院期间和之后的死亡率极高。